We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Robotic Tech | LSE:RTS | London | Ordinary Share | GB0007614935 | ORD 1P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 3.25 | 0.00 | 01:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 3.25 | GBX |
Robotic Technology (RTS) Share Charts1 Year Robotic Technology Chart |
|
1 Month Robotic Technology Chart |
Intraday Robotic Technology Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 13/7/2012 | 20:07 | Re-organised RTS a winner after Wright own-goal? | 1,420 |
| 05/3/2008 | 07:51 | rts | - |
| 08/2/2008 | 20:14 | Robotic Technology with Charts & News | - |
| 26/6/2006 | 21:46 | International Nuclear Solutions - lists 30 May - buy now!! | 4 |
| 29/4/2004 | 14:42 | Robotic Technolgy - Big rise bubbling up !! | 373 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 13/7/2012 19:44 by pentangle Not sure if anyone else did not sell out. However, the Robotic Legacy company, which holds the legacy assets including the loan notes, paid out a divi of £210 a share today. |
Posted at 21/10/2011 16:16 by pentangle £500 per share which equates to 2p per old share. |
Posted at 13/1/2011 08:28 by chrisdgb Well I am back in here this morning, used to hold RTS.Crazy price now given the cash and tax losses... Let us hope the shrewd IAV can get a decent acquistion... Could well be a long term multi bagger... I suppose we need a new thread as well.. |
Posted at 11/1/2011 15:39 by pentangle If they all sat around and did nothing, the payout should be 7p a share, assuming the loan notes which make up about half of this get paid by Doerfer (a US company which RTS sold a subsidiary to and who gave loan notes in part payment).The problem is that the Directors have threatened to use their 'expertise' to invest the money in other companies which opens the very real possibility that they will fritter the money away. So, no, its not fair to say there is no chance of shareholder value. There is every chance, but there is a risk. |
Posted at 08/12/2010 13:28 by nailsaz pentangle,I did a bit of research into the court case after the Supreme court ruling (i actually trained as a lawyer originally). The whole process seemed to be a bit of a vanity exercise for RTS. I think the original contract was around £1.7m in 2005 but you have to dig into the fine print to see that Muller actually paid 70% of this in 3 payments and the legal proceedings were over the final payment of a little over 500k. This is a sizeable amount but from looking at RTS's annual statements since 2005 I can see approximately £1.5 million in legal costs spent on recovering this. Im not 100% sure if all these costs were cash flows or simply balance sheet provisions (which has huge impact on the actual costs recoverable from Muller). I would imagine Muller will have to pay the 30% of contract and reasonable costs. This would seem more certain in my view than the Doerfer loan notes but im not sure why it has taken since March to hear news. |
Posted at 07/12/2010 13:25 by pentangle NailsazIn the disposal document it referred to the following assets: Cash - £2.0m or 3.2p a share Loan Notes - £2.3m or 3.65p per share (plus interest of $1m to 2014 or 1.0p per share) R&D Tax Credits - up to £250k or .4p a share Legal Dispute - unknown, possible recovery of costs and payment due to Flexible Systems? Thus if the loan notes perform, and we assume nothing from the tax credits and the legal battle that gives us 7.85p per share. The rest is upside. What really worries me is the implied threat also contained in the disposal document ie 'The Company will draw on the deep expertise of the Directors in engineering and industrial technology in order to differentiate it from pure financial investors, but will benefit from the application of the same financial disciplines.' These guys have do not have the greatest record at RTS (or HEP as I guess we should get used to calling it), and I imagine they are quite capable of frittering away this shareholder value. So the jury is out, though I obviously hope they succeed. BTW Doerfer are a large private US company, hence no figures available, but who have clearly struggled to pay these loan notes. Therefore getting them paid is not a given. |
Posted at 05/12/2010 20:21 by nailsaz Pentangle, Im holding this too. The way I understand it the company currently has 2 million in cash and is owed a further 2 million by doerffer. By merely collecting this and not receiving any costs order from the legal battle we are worth 6p a share. that doesnt seem an enormous risk for 100% return does it?what/who are doerfer and why are they dragging their heels so much? |
Posted at 01/12/2010 22:13 by pentangle I really think that if the gents running the company want to maximise shareholder value they should consider sacking themselves and employing someone on £20,000 a year for a day a week to collect in the legacy assets - well perhaps £5,000 a year and a day a month would be enough.That way the long suffering shareholders could pick up 7-8p a share. I do not have a lot of confidence in the Directors to use their 'expertise' to improve on that. Not unless they can engineer a decent reverse takeover. Even then, if they really want to look after existing shareholders, they should insist on them getting some sort of differentiated class of shares which would enable them to benefit from the legacy assets. Not overly convinced that halving the face value of the Loan Notes and letting the business go for £600,000 has done a lot to maximise shareholder value. |
Posted at 14/9/2010 07:52 by pentangle Results out. Nothing to write home about.Bit peeved they have given up half the Doerfer loan notes in exchange for an improved payments schedule. I would have thought that in exchange for paying the other half now would have been more appropriate. Of course, you do not know what the balance of power was at the negotiations or the state Doerfer are in since it is a private company. Not very positive though. The bright spots seem to be an improved order book and the fact that they have started receiving their legal fees back from that long running court case where they have received a favourable ruling - £80,000 received back so far. Think we will have to wait for any fireworks in the share price. |
Posted at 07/1/2010 15:31 by chrisdgb this is the sort of thing in the life sciences division:RTS Life Science Launches Tube Auditor with Unique Vision Technology 04/12/2009 Manchester, UK (December 4, 2009) RTS Life Science, a worldwide supplier of automated sample management and drug delivery testing systems announces the launch of its innovative Tube Auditor instrument. With units already on order from 3 of the top 10 pharma and a major US Biobank, the Tube Auditor features unique vision technology, (patent pending*) allowing for fast and accurate volume measurement of samples, and is targeted at the Compound Management, High Throughput Screening and Bio-banking marketplace. RTS Life Science will unveil this new instrument on booth #644 at LabAutomation, which will take place at the Palm Springs Convention Center, Palm Springs, CA from January 23-27, 2010. The RTS Tube Auditor is a bench-top instrument suitable for manual operation or integration into automated systems. It enables fast and accurate measurement of sample volumes and, uniquely, the detection of precipitate in sample tubes. Its high speed vision technology allows a full 96-way SBS tube rack to be audited in less than 2 minutes. Unlike other automated solutions, the RTS Tube Auditor ensures complete sample safety and avoids the potential for sample degradation as there is no need to de-cap tubes during the auditing process. During LabAutomation 2010, RTS Life Science will be hosting a workshop in collaboration with Microsonics Systems. The workshop, entitled "See and Hear how Vision and Acoustic Technology Could save $$$ in Your Screening and Library Collection," will highlight how two complementary technologies can minimise poor quality screening and improve results by finding and then correcting solubility issues within compound libraries. With a focus on the new Tube Auditor and its innovative vision technology, and how Microsonics use ultrasonic energy to re-solubilise compounds, this workshop is sure to be of great interest. The workshop will take place on Tuesday, January 26, 2010 at 12:30 2:00p.m in the Convention Center, room Smoketree DE. To register, click here. In addition, RTS Life Science will present two new posters at LabAutomation 2010. One of these posters, entitled "Improving Screening Results Using Vision Technology", will demonstrate the many benefits of using RTS vision technology to routinely and accurately audit sample tubes. These benefits include minimising costs from wasted screening of empty plate wells, and avoiding screening samples at the wrong concentration by early detection of precipitated samples. A competition will also take place on the booth where visitors will be able to estimate the volume of sample in a tube with the closest standing the chance to win an iPod touch. With 25 years of experience delivering automation solutions, RTS Life Science is a major supplier of large scale sample storage and testing within the laboratory environment. To learn more about RTS Life Science's revolutionary Tube Auditor or to enter the competition, please visit booth #644 at LabAutomation 2010. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
